Editorial: Therapeutics in pulmonary arterial hypertension

• Rui Adão,
• Rui Adão,
• Rui Adão,
• Rui Adão,
• Francisco Perez-Vizcaino,
• Francisco Perez-Vizcaino,
• Francisco Perez-Vizcaino,
• Bassam Redwan,
• Bassam Redwan,
• Carmen Brás-Silva,
• Carmen Brás-Silva

Affiliations

Rui Adão

Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal

Rui Adão

Department of Pharmacology and Toxicology, School of Medicine, University Complutense of Madrid, Madrid, Spain

Rui Adão

CIBER Enfermedades Respiratorias (Ciberes), Madrid, Spain

Rui Adão

Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

Francisco Perez-Vizcaino

Department of Pharmacology and Toxicology, School of Medicine, University Complutense of Madrid, Madrid, Spain

Francisco Perez-Vizcaino

CIBER Enfermedades Respiratorias (Ciberes), Madrid, Spain

Francisco Perez-Vizcaino

Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

Bassam Redwan

Department of Thoracic Surgery, Klinik am Park, Klinikum Westfalen, Lünen, Germany

Bassam Redwan

Faculty of Medicine, University of Witten Herdecke, Witten, Germany

Carmen Brás-Silva

Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal

Carmen Brás-Silva

Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal